Pertussis: A concise historical review including diagnosis, incidence, clinical manifestations and the role of treatment and vaccination in management

Reviews and Research in Medical Microbiology

Volumn 16, Issue 3, 2005, Pages 79-89

  Versteegh, Florens G A ^a   Schellekens, Joop F P ^b   Fleer, André ^c   Roord, John J ^d  

^a GROENE HART HOSPITAL   (Netherlands)

^b Laboratory for Infectious Diseases   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Current concepts; Diagnosis; History; Pathogenesis; Pertussis; Prevention; Re infection; Review

Indexed keywords

ACELLULAR VACCINE; AZITHROMYCIN; CLARITHROMYCIN; COTRIMOXAZOLE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; ERYTHROMYCIN; IMMUNOGLOBULIN G ANTIBODY; PERTUSSIS VACCINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

AGE DISTRIBUTION; BACTERIAL IMMUNITY; BACTERIAL TRANSMISSION; BACTERIUM DETECTION; BORDETELLA PERTUSSIS; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; ENZYME IMMUNOASSAY; EPIDEMIC; HOST RESISTANCE; HUMAN; HYPERTROPHIC PYLORUS STENOSIS; IMMUNIZATION; INCIDENCE; INFLUENZA; NONHUMAN; PATHOGENESIS; PERTUSSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; RNA VIRUS INFECTION; SEROLOGY; SIDE EFFECT; VACCINATION; VIRUS INFECTION;

EID: 23044469363     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.revmedmi.0000175933.85861.4e     Document Type: Review

References (112)

1. Baillou G. Constitutio aestiva. In: Classic Description of Disease, 3rd edn, 6th print. Edited by Major RH. Springfield, IL: Charles C Thomas; 1965. pp. 210-212.
2. Kohn GC. Cough of Perinthus. In: The Wordsworth Encyclopedia of Plague and Pestilence. Ware, Hertfordshire: Wordsworth Editions Ltd; 1998. p. 66.
3. Simpson JA, Weiner ESC (eds) Oxford English Dictionary. 2nd edn. 1989 Additions 1993-7 and 3rd edn (in preparation) March 2000 (ed. John Simpson). OED Online. Oxford University Press. http://oed.com.
4. Middelnederlandsch Woordenboek op cd-rom. 's-Gravenhage: Sdu Uitgevers, 1998 (E.Verwijs en J.Verdam, Middelnederlandsch Woordenboek. Delen I-IX. 's-Gravenhage: Martinus Nijhoff 1885-1929).
5. Lieburg MJ van. De Geschiedenis van de Kindergeneeskunde in Nederland. Rotterdam: Erasmus Publishing; 1997:25, 159.
6. Rosén von Rosenstein N, von dem Keichhusten. In: Anweisung zur Kenntniß und Kur der Kinderkrankheiten. Göttingen: JC Dieterich; 1798:417-439.
7. Schiller K, Lübben A. Mittelniederdeutsches Wörterbuch. Delen 1-6. Wiesbaden/Münster: Dr. Martin Sandig iHG/ Aschendorffsche Verlagsbuchhandlung, 1875-1881 (Fotomech. herdruk 1969).
8. Dodoens (= Dodonaeus) R. Cruijde Boeck. In: den welcken die gheheele historie (...) van den Cruyden (...) met grooter neersticheyt begrepen ende verclaert es (...). Antwerpen, 1554.
9. Goodall EW. A French epidemiologist of the sixteenth century. Annals Med History 1935; VII, 5:409-427.
10. Holmes WH. Bacillary and Rickettsial Infections: Acute and Chronic, Black Death to White Plague. New York: Macmillan; 1940; pp. 395-414.
11. Cherry JD, Heininger U. Pertussis and Other Bordetella Infections. In: Textbook of Pediatric Infectious Diseases. Edited by Feigin RD, Cherry JD, Demmler GJ, Kaplan SL. Philadelphia: Saunders; 2004. pp. 1588-1608. Permission from Elsevier.
12. No authors listed. Pertussis. JAMA 1967; 202:357-358.
13. Long SS. Bordetella pertussis (Pertussis) and other species. In: Pediatric Infectious Diseases. Edited by Long, Pickering, Prober. New York: Churchill Livingstone; 1997:976-986.
14. Esso I van. De etymologie der woorden 'kinkhoest', 'mazelen', 'roode bond', 'bof', 'quinte de toux' en 'coqueluche'. Ned Tijdschr Geneeskd 1936, 80 III:3565-3566.
15. Met Woordenboek der Nederlandsche Taal op CD-Rom. (Delen I-XXIX met Supplementdeel en Aanvullingen). 's-Gravenhage: Sdu Uitgevers, 2003.
16. (M. de Vries, L.A. te Winkel et al. Woordenboek der Nederlandsche Taal. Delen I-XXIX met Supplementdeel. 's-Gravenhage/Leiden etc.: M. Nijhoff/A.W. Sijthoff etc., 1882-1998. Aanvullingen delen I-III. 's-Gravenhage: Sdu Uitgevers, 2001).
17. Dodonaeus R. Herbarius oft Cruydt-Boeck. Leiden, 1608.
18. Connor JD. Evidence for an etiologic role of adenoviral infection in pertussis syndrome. N Engl J Med 1970; 283:390-394.
19. Sturdy PM, Court SDM, Gardner PS. Viruses and whooping-cough. Lancet 1971; 2 (7731):978-979.
20. Nelson KE, Gavitt F, Batt MD, Kallick CA, Reddi KT, Levin S. The role of adenoviruses in the pertussis syndrome. J Pediatr 1975; 86:335-341.
21. Wirsing von König CH, Rott H, Bogaerts H, Schmitt HJ. A serological study of organisms possibly associated with pertussis-like coughing. Pediatr Infect Dis J 1998; 17:645-649.
22. Tristram DA, Miller RW, McMillan JA, Weiner LB. Simultaneous infection with respiratory syncytial virus and other respiratory pathogens. Am J Dis Child 1988; 12:834-836.
23. Aoyama T, Ide Y, Watanabe J, Takeuchi Y, Imaizumi A. Respiratory failure caused by dual infection with Bordetella pertussis and respiratory syncytial virus. Acta Paediat Japon 1996; 38:282-285.
24. Hagiwara K, Ouchi K, Tashiro N, Azuma M, Kobayashi K. An epidemic of a pertussis-like illness caused by Chlamydia pneumoniae. Pediatr Infect Dis J 1999; 18:271-275.
25. Christie CDC, Baltimore RS. Pertussis in neonates. Am J Dis Child 1989; 143:1199-1202.
26. Güris D, Strebel PM, Bardenheier B, Brennan M, Tachdjian R, Finch E, Wharton M, Livengood JR. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 1999; 28:1230-1237.
27. Heininger U, Klich K, Stehr K, Cherry JD. Clinical findings in Bordetella pertussis infections: results of a prospective multicenter surveillance study. Pediatrics 1997; 100:E10.
28. Bordet J, Gengou O. Le microbe de la coqueluche. Ann Inst Pasteur 1906; 20:731-741.
29. Bradford WL, Slavin B. An organism resembling Hemophilus pertussis, with special reference to color changes produced by its growth upon certain media. Am J Public Health 1937; 27:1277-1282.
30. Eldering G, Kendrick PL. Bacillus parapertussis: a species resembling both Bacillus pertussis and Bacillus bronchisepticus but identical with neither. J Bacteriol 1938; 35:561-572.
31. Ferry NS. Bacillus bronchisepticus (bronchicanis): the cause of distemper in dogs and a similar disease in other animals. Veterinary J 1912; 68:376-391.
32. Kersters K, Hinz KH, Hertle A, Segers P, Lievens A, Siegmann O, De Ley J. Bordetella avium sp. nov., isolated from the respiratory tracts of turkeys and other birds, Int J Syst Bacteriol 1984; 34:56-70.
33. Cookson BT, Vandamme P, Carlson LC, Larson AM, Sheffield JV, Kersters K, Spach DH. Bacteremia caused by a novel Bordetella species, 'B. hinzii'. J Clin Microbiol 1994; 32:2569-2571.
34. Vandamme P, Hommez J, Vancanneyt M, Monsieurs M, Hoste B, Cookson B, et al. Bordetella hinzii sp. nov., isolated from poultry and humans. Int J Syst Bacteriol 1995; 45:37-45.
35. Weyant RS, Hollis DG, Weaver RE, Amin MF, Steigerwalt AG, O'Connor SP, et al. Bordetella holmesii sp. nov., a new gram-negative species associated with septicemia. J Clin Microbiol 1995; 33:1-7.
36. Vandamme P, Heyndrickx M, Vancanneyt M, Hoste B, De Vos P, Falsen E, et al. Bordetella trematum sp. nov., isolated from wounds and ear infections in humans, and reassessment of Alcaligenes denitrificans Ruger and Tan 1983. Int J Syst Bacteriol 1996; 46:849-858.
37. Wintzingerode F von, Schattke A, Siddiqui RA, Rosick U, Gobel UB, Gross R. Bordetella petrii sp. nov., isolated from an anaerobic bioreactor, and emended description of the genus Bordetella. Int J Syst Evol Microbiol 2001; 51:1257-1265.
38. Woolfrey BF, Moody JA. Human infections associated with Bordetella bronchiseptica. Clin Microbiol Rev 1991; 4:243-255.
39. Finger H, Wirsing von Koenig CH. Bordetella. In: Medical Microbiology. Edited by Baron S. Galveston: The University of Texas Medical Branch; 1996. pp. 403-412.
40. Hewlett EL. Pertussis: current concepts of pathogenesis and prevention. Ped Infect Dis J 1997; 16:S78-S84.
41. Madan BM, Bhargavi J, Ranajeet SS, Kumar SS. Virulence factors of Bordetella pertussis. Curr Science 2001; 80:1512-1522.
42. Laing JS, Hay M. Whooping-cough: its prevalence and mortality in Aberdeen. Public Health 1902; 14:584-598.
43. Cherry JD. Pertussis in the preantibiotic and prevaccine era, with emphasis on adult pertussis. Clin Infect Dis 1999; 28 (Suppl 2):S107-S111.
44. Taranger J, Trollfors B, Lagergård T, Zackrisson G. Parapertussis infection followed by pertussis infection. Lancet 1994; 344:1703.
45. Cherry JD, Gornbein J, Heininger U, Stehr K. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 1998; 16:1901-1906.
46. Storsaeter J, Hallander HO, Gustafsson L, Olin P. Levels of antipertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 1998; 16:1907-1916.
47. Storsaeter J, Hallander HO, Gustafsson L, Olin P. Low levels of antipertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis. Vaccine 2003; 21:3542-3549.
48. Hellwig SMM, Rodriguez ME, Berbers GAM, Van de Winkel, JGJ, Mooi FR. Crucial role of antibodies to pertactin in Bordetella pertussis immunity. J Infect Dis 2003; 188:738-742.
49. Tonon S, Goriely S, Aksoy E, Pradier O, Del Giudice G, Trannoy E, et al. Bordetella pertussis toxin induces the release of inflammatory cytokines and dendritic cell activation in whole blood: impaired responses in human newborns. Eur J Immunol 2002; 32:3118-3125.
50. Ausiello CM, Lande R, Urbani F, Di Carlo B, Stefanelli P, Salmaso S, et al. Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine. J Infect Dis 2000; 181:1989-1995.
51. Tran Minh NN, He Q, Edelman K, Olander RM, Viljanen MK, Arvilommi H, et al. Cell-mediated immune responses to antigens of Bordetella pertussis and protection against pertussis in school children. Pediatr Infect Dis J 1999; 18:366-370.
52. No authors listed. Pertussis vaccines. WHO-Weekly Epidemiological Record. 1999; 74(18):137-142.
53. Greeff SC de, Schellekens JFP, Mooi FR, Melker HE de. Pertussis in the Netherlands 2001-2002. RIVM rapport 128507010/2003. http://www.rivm.nl/ bibliotheek/rapporten/ 128507010.html
54. WHO-Pertussis Surveillance. WHO/V&B/01.19.
55. http://www.who.int/vaccines/globalsummary/timeseries/tsincidenceper.htm
56. No authors listed. National consensus conference on pertussis, Toronto, May 25-28, 2002. Can Commun Dis Rep 2003; 29 (Suppl 3):1-33.
57. http://www.ssi.dk/graphics/html/EUVAC/index.html
58. Melker HE de, Conyn-van Spaendonck MAE, Rumke HC, van Wijngaarden JK, Mooi FR, Schellekens JFP. Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine. Emerg Infect Dis 1997; 3: 175-178.
59. Neppelenbroek SE, Melker HE de, Schellekens JFP, Conyn-van Spaendonck MAE. The incidence of pertussis in the Netherlands has remained high since an outbreak occurred in 1996. Euro Surveil 1999; 4:133-134.
60. Melker HE de, Schellekens JFP, Neppelenbroek SE, Mooi FR, Rumke HC, Conyn-van Spaendonck MAE. Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerg Infect Dis 2000; 6:348-357.
61. Feer E. Ueber das Wesen und über die Infektionsverhältnisse des Keuchhustens. Med Klinik 1914; 10:837-841.
62. Luttinger P. The epidemiology of pertussis. Am J Dis Child 1916; 12:290-315.
63. Schwenkenbecher A. Keuchhusten bei Erwachsenen. Med Klin 1921; 17:1447-1448.
64. Schlack H. Der Keuchhusten der Erwachsenen. Munch Med Wochenschr 1938; 85:1541-1544.
65. Gordon JE, Hood RI. Whooping cough and its epidemiological anomalies. Am J Med Sci 1951; 222:333-361.
66. Mooi FR, Loo IHM van, King AJ. Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence? Emerg Infect Dis 2001; 7(3 Suppl):526-528.
67. Rohani P, Earn DJD, Grenfell B. Impact of immunisation on pertussis transmission in England and Wales. Lancet 2000; 355:285-286.
68. Mink CAM, Sirota NM, Nugent S. Outbreak of pertussis in a fully immunized adolescent and adult population. Arch Pediatr Adolesc Med 1994; 148:153-157.
69. Gilberg S, Njamkepo E, Parent du Chatelet I, Partouche H, Gueirard P, Ghasarossian C, et al. Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a French area with very high whole-cell vaccine coverage. J Infect Dis 2002; 186:415-418.
70. Senzilet LD, Halperin SA, Spika JS, Alagaratnam M, Morris A, Smith B. Sentinel Health Unit Surveillance System Pertussis Working Group. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis 2001; 3212:1691-1697; Epub 2001 May 21.
71. Long SS, Welkon CJ, Clark JL. Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology. J Infect Dis 1990; 161:480-486.
72. He Q, Viljanen MK, Nikkari S, Lyytikäinen R, Mertsola J. Outcomes of Bordetella pertussis infection in different age groups of an immunized population. J Infect Dis 1994; 170:873-877.
73. Schellekens JFP, Melker HE de. Laboratoriumdiagnostiek van infecties met Bordetella spp. bij patiënt en populatie. Ned Tijdschr Med Microbiol 2000; 8:112-116.
74. Zee A van der, Agterberg C, Peeters M, Mooi F, Schellekens J. A clinical validation of Bordetella pertussis and Bordetella parapertussis polymerase chain reaction: comparison with culture and serology using samples from patients with suspected whooping cough from a highly immunized population. J Infect Dis 1996; 174:89-96.
75. Bordet J, Gengou O. Le diagnostic de la coqueluche fruste par la méthode de la fixation de lálexine. Zentralbl Bakteriol Parasitenkd Infektionskr Hyg Abt 1 Orig 1911:58-68.
76. Müller F-MC, Hoppe JE, Wirsing von König CH. Laboratory diagnosis of pertussis: state of the art in 1997. J Clin Microbiol 1997; 35:2435-2443.
77. Nagel J, de Graaf S, Schijf-Evers D. Improved serodiagnosis of whooping cough caused by Bordetella pertussis by determination of IgG anti-LPF antibody levels. Dev Biol Stand 1985; 61:325-330.
78. Tomoda T, Ogura H, Kurashige T. Immune responses to Bordetella pertussis infection and vaccination. J Infect Dis 1991; 163:559-563.
79. Bergquist SO, Bernander S, Dahnsjo H, Sundelof B. Erythromycin in the treatment of pertussis: a study of bacteriologic and clinical effects. Pediatr Infect Dis J 1987; 6:458-461;
80. Erratum in Pediatr Infect Dis J 1987; 6:1035.
81. Aoyama T, Sunakawa K, Iwata S, Takeuchi Y, Fujii R. Efficacy of short-term treatment of pertussis with clarithromycin and azithromycin. J Pediatr 1996; 129:761-764.
82. Lebel MH, Mehra S. Efficacy and safety of clarithromycin versus erythromycin for the treatment of pertussis: a prospective, randomized, single blind trial. Pediatr Infect Dis J 2001; 20:1149-1150.
83. Langley JM, Halperin SA, Boucher FD, Smith B. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC): Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis. Pediatrics 2004; 114:e96-e101.
84. Halperin SA, Bortolussi R, Langley JM, Miller B, Eastwood BJ. Seven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infections. Pediatrics 1997; 100:65-71.
85. Bace A, Zrnic T, Begovac J, Kuzmanovic N, Culig J. Short-term treatment of pertussis with azithromycin in infants and young children. Eur J Clin Microbiol Infect Dis 1999; 18:296-298.
86. No authors listed. Erythromycin-resistant Bordetella pertussis-Yuma County, Arizona, May-October 1994. MMWR 1994; 43:807-810.
87. Lewis K, Saubolle MA, Tenover FC, Rudinsky MF, Barbour SD, Cherry JD. Pertussis caused by an erythromycin-resistant strain of Bordetella pertussis. Pediatr Infect Dis J 1995; 14:388-391.
88. Hauben M, Amsden CW. The association of erythromycin and infantile hypertrophic pyloric stenosis: causal or coincidental? Drug Safety 2002; 25:929-942.
89. Honein MA, Paulozzi LJ, Himelright IM, Lee B, Cragan JD, Patterson L, et al. Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromcyin: a case review and cohort study. Lancet 1999; 354:2101-2105;
90. Erratum in Lancet 2000; 355:758.
91. Hoppe JE, Halm U, Hagedorn HJ, Kraminer-Hagedorn A. Comparison of erythromycin ethylsuccinate and co-trimoxazole for treatment of pertussis. Infection 1989; 17:227-231;
92. Erratum in Infection 1989, 17:330.
93. Preston NW, Kerr JR. Current pharmacotherapy of pertussis. Expert Opin Pharmacother 2001; 2:1275-1282.
94. Dekking F. Behandeling van pertussis met hyperimmune gammaglobuline. Ned Tijdschr Geneeskd 1972; 116:1023.
95. Ichimaru T, Ohara Y, Hojo M, Miyazaki S, Harano K, Totoki T. Treatment of severe pertussis by administration of specific gamma globulin with high titers anti-toxin antibody. Acta Paediatr 1993; 82:1076-1078.
96. Casey PA. Altitude treatment for whooping cough. BMJ 1991; 302:1212.
97. Hall D. Altitude treatment for whooping cough. BMJ 1991; 303:58.
98. Küster F. Unterdrucktherapie bei Keuchhusten. Dtsch Med Wochenschr 1971; 96:1814.
99. Kostadima E, Tsiodras S, Alexopoulos EI, Kaditis AG, Mavrou I, Georgatou N, et al. Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma. Eur Respir J 2004; 23:714-717.
100. LCI-protocol Pertussis-kinkhoest. Den Haag, LCI 1999/2000.
101. Jefferson T, Rudin M, DiPietrantonj C. Systematic review of the effects of pertussis vaccines in children. Vaccine 2003; 21:2003-2014.
102. Versteegh FGA, Schellekens JFP, Nagelkerke AF, Roord JJ. Laboratory-confirmed reinfections with Bordetella pertussis. Acta Paediatr 2002; 91:95-97.
103. Melker HE de, Versteegh FGA, Conyn-Van Spaendonck MA, Elvers LH, Berbers GA, van der Zee A, et al. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol 2000; 38:800-806.
104. Baughman AL, Bisgard KM, Edwards KM, Guris D, Decker MD, Holland K, et al. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clin Diagn Lab Immunol 2004; 11:1045-1053.
105. Giammanco A, Chiarini A, Maple PAC, Andrews N, Pebody R, Gay N, et al. European sero-epidemiology network: standardisation of the assay results for pertussis. Vaccine 2003; 22:112-120.
106. Teunis PFM, Heijden OG van der, Melker HE de, Schellekens JFP, Versteegh FGA, Kretzschmar M. Kinetics of the IgG antibody response to pertussis toxin after infection with Bordetella Pertussis. Epidemiol Infect 2002; 129:479-489.
107. Versteegh FGA, Mertens PLJM, Melker HE de, Roord JJ, Schellekens JFP, Teunis PFM. Age-specific long-term course of IgG antibodies to pertussis toxin after symptomatic infection with Bordetella pertussis. Epidemiol Infect (in press).
108. Bisgard KM, Pascual FB, Ehresmann KR, Miller CA, Cianfrini C, Jennings CE, et al. Infant pertussis: who was the source? Pediatr Infect Dis J 2004; 23:985-989.
109. Versteegh FGA. Pertussis: new insights in diagnosis, incidence and clinical manifestations. Thesis 2005:89-104.
110. Forsyth KD, Campins-Marti M, Caro J, Cherry JD, Greenberg D, Guiso N, et al. Global Pertussis Initiative: New pertussis vaccination strategies beyond infancy: recommendations by the Global Pertussis Initiative. Clin Infect Dis 2004; 39:1802-1809. Epub 2004 Dec 15.
111. Versteegh FGA. Pertussis: new insights in diagnosis, incidence and clinical manifestations. Thesis 2005:117-127.
112. Versteegh FGA, Weverling GJ, Peeters MF, Wilbrink B, Veenstra-van Schie MTM, Leeuwen-Gerritsen JM van, et al. Pathogens in community acquired coughing in children: a prospective cohort study. Clin Microbiol Infect (in press).